Stockscreener 앱 받기
0.00
100.00%
-18.20
전일 마감가:
$18.20
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$6.08M
수익:
-
순이익/손실:
$-77.39M
주가수익비율:
0.00
EPS:
-2.53
순현금흐름:
$-63.90M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$19.30
리네오 파마슈티컬스 Stock (RPHM) Company Profile
명칭
Reneo Pharmaceuticals Inc
전화
(858) 283-0280
주소
18575 JAMBOREE ROAD, IRVINE
RPHM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPHM
Reneo Pharmaceuticals Inc
|
0.00 | 6.08M | 0 | -77.39M | -63.90M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
482.28 | 124.20B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
697.05 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
651.30 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.00 | 34.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.14 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
리네오 파마슈티컬스 Stock (RPHM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-05 | 개시 | Leerink Partners | Outperform |
| 2024-10-10 | 개시 | Oppenheimer | Outperform |
| 2023-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-12-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-12-15 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-12-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2023-12-14 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-11-15 | 개시 | William Blair | Outperform |
| 2023-08-28 | 개시 | H.C. Wainwright | Buy |
| 2023-07-03 | 개시 | BofA Securities | Buy |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-01-27 | 개시 | Robert W. Baird | Outperform |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-22 | 개시 | Ladenburg Thalmann | Buy |
| 2021-05-04 | 개시 | Jefferies | Buy |
| 2021-05-04 | 개시 | Piper Sandler | Overweight |
| 2021-05-04 | 개시 | SVB Leerink | Outperform |
모두보기
리네오 파마슈티컬스 주식(RPHM)의 최신 뉴스
Reneo Pharmaceuticals stock hits 52-week low at $7.64 - Investing.com India
Reneo Pharmaceuticals stock hits 52-week low at $7.91 By Investing.com - Investing.com Nigeria
Reneo Pharmaceuticals stock hits 52-week low at $7.91 - Investing.com
OnKure Therapeutics Reports Strategic Merger and Financial Updates - TipRanks
Head to Head Survey: OnKure Therapeutics (OKUR) vs. Its Rivals - Defense World
Analysis of TANG CAPITAL MANAGEMENT LLC's Recent Transaction in Reneo Pharmaceuticals Inc - GuruFocus.com
Highbridge Capital Management LLC Increases Stake in Reneo Pharm - GuruFocus.com
Form 424B3 OnKure Therapeutics, - StreetInsider.com
Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Reneo Pharmaceuticals (NASDAQ:RPHM) Stock Price Up 5.2% – Here’s What Happened - Defense World
Octagon Capital Advisors LP Adjusts Stake in Reneo Pharmaceutica - GuruFocus.com
Deep Track Capital, LP's Strategic Acquisition in Reneo Pharmace - GuruFocus.com
Analysts Offer Predictions for OKUR Q1 Earnings - Defense World
What is HC Wainwright's Estimate for OKUR Q1 Earnings? - MarketBeat
OnKure Therapeutics (NASDAQ:OKUR) Earns Buy Rating from HC Wainwright - MarketBeat
OnKure Therapeutics (OKUR) Stock Rebounds In Extended Session - Stocks Telegraph
Cormorant Asset Management's Strategic Acquisition of Reneo Pharmaceuticals Shares - Yahoo Finance
Deep Track Capital's Strategic Investment in Reneo Pharmaceuticals - Yahoo Finance
Deep Track Capital's Strategic Investment in Reneo Pharmaceutica - GuruFocus.com
OnKure shares initiated with Outperform rating on drug potential - Investing.com India
Perceptive Advisors LLC Acquires New Stake in Reneo Pharmaceuticals Inc - Yahoo Finance
Carlyle Group Inc. Reduces Stake in Reneo Pharmaceuticals Inc. - GuruFocus.com
Recently Listed Cancer Firm OnKure’s Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm - EMEA Tribune, Breaking News, World News, Latest News, Top Headlines
OnKure shares initiated with Outperform rating on drug potential By Investing.com - Investing.com Canada
Reneo Pharmaceuticals Completes Merger and Name Change to OnKure Therapeutics, Inc. - MarketBeat
Reneo Pharmaceuticals: Navigating Financial Challenges and Corporate Changes - TipRanks
Newley merged OnKure raises $65 million - The Pharma Letter
Boulder’s OnKure goes public with merger; key drug trial underway - Boulder Daily Camera
OnKure and Reneo Pharmaceuticals complete merger - Yahoo Finance
Reneo Pharmaceuticals stockholders approval merger with OnKure - TipRanks
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million - ForexTV.com
Reneo stockholders approve merger with OnKure - MSN
Reneo Pharmaceuticals secures stockholder approval for OnKure merger By Investing.com - Investing.com Australia
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure - StockTitan
Reneo Pharmaceuticals' Shareholders Approve Merger With OnKure; Reverse Stock Split Imminent - Marketscreener.com
Reneo Pharmaceuticals secures stockholder approval for OnKure merger - Investing.com India
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure - Benzinga
Point72 Asia Singapore Pte. Ltd. Takes Position in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) - Defense World
Nantahala Capital Management LLC Invests $846,000 in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) - Defense World
Reneo Pharmaceuticals Inc [RPHM] stock for 102,872 USD was bought by Leonard Braden Michael - Knox Daily
Braden Michael Leonard Purchases 29,600 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Stock - MarketBeat
Reneo Pharmaceuticals executive buys shares worth over $144k - Investing.com India
Reneo Pharmaceuticals executive buys shares worth over $144k By Investing.com - Investing.com Canada
리네오 파마슈티컬스 (RPHM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.02%
0.32%
자본화:
|
볼륨(24시간):